You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TEVA Sale Disclosure
Mignone Roberto · SEC Form 4 · Filed Sep 22, 2026
Sale
Calculated transaction value
$14.36M
Mignone Roberto Director
TEVA
Transaction date
Sep 18, 2026
Public filing date
Sep 22, 2026
Filing lag
Filed 4 days later
TEVA daily price context
Close on/before transaction
$38.98
Sep 18, 2026
First close after public filing
$39.01
Sep 23, 2026
30-day return after filing
+3.08%
Through Oct 22, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 367,600 shares @ $39.06
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-397959
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$14.36M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd TEVA Current | Sale | Sep 18, 2026 | $14.36M |